Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HYPR NASDAQ:NNOX NASDAQ:RCEL OTCMKTS:VASO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHYPRHyperfine$1.36-4.2%$1.43$0.66▼$2.22$135.01M1.38488,790 shs464,071 shsNNOXNano-X Imaging$1.76+2.9%$1.98$1.59▼$5.69$122.48M1.211.18 million shs663,592 shsRCELAvita Medical$3.91-1.5%$4.39$3.22▼$7.12$120.34M1.87266,189 shs258,701 shsVASOVaso$0.19+1.2%$0.19$0.11▼$0.25$33.44M0.56177,332 shs71,209 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHYPRHyperfine-4.23%-1.45%-14.47%+19.30%+63.09%NNOXNano-X Imaging+2.92%-8.81%-1.68%-30.43%-67.47%RCELAvita Medical-1.51%-6.46%-8.22%-11.14%-35.48%VASOVaso+0.53%-2.56%-0.47%+15.15%+47.98%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHYPRHyperfine$1.36-4.2%$1.43$0.66▼$2.22$135.01M1.38488,790 shs464,071 shsNNOXNano-X Imaging$1.76+2.9%$1.98$1.59▼$5.69$122.48M1.211.18 million shs663,592 shsRCELAvita Medical$3.91-1.5%$4.39$3.22▼$7.12$120.34M1.87266,189 shs258,701 shsVASOVaso$0.19+1.2%$0.19$0.11▼$0.25$33.44M0.56177,332 shs71,209 shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHYPRHyperfine-4.23%-1.45%-14.47%+19.30%+63.09%NNOXNano-X Imaging+2.92%-8.81%-1.68%-30.43%-67.47%RCELAvita Medical-1.51%-6.46%-8.22%-11.14%-35.48%VASOVaso+0.53%-2.56%-0.47%+15.15%+47.98%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHYPRHyperfine 2.33Hold$1.7831.13% UpsideNNOXNano-X Imaging 2.83Moderate Buy$5.00184.09% UpsideRCELAvita Medical 2.33Hold$7.2585.42% UpsideVASOVaso 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest VASO, HYPR, NNOX, and RCEL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2026RCELAvita Medical Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$3.50 ➝ $6.005/13/2026HYPRHyperfine B. Riley FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy4/29/2026HYPRHyperfine BTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$2.004/22/2026NNOXNano-X Imaging Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell4/21/2026HYPRHyperfine Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/20/2026NNOXNano-X Imaging D. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$5.004/13/2026NNOXNano-X Imaging D. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$5.004/10/2026NNOXNano-X Imaging Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/8/2026RCELAvita Medical D. Boral CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$10.003/27/2026RCELAvita Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)3/19/2026HYPRHyperfine Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold(Data available from 6/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHYPRHyperfine$11.40M11.84N/AN/A$0.42 per share3.24NNOXNano-X Imaging$13.02M9.41N/AN/A$2.01 per share0.88RCELAvita Medical$71.61M1.68N/AN/A($0.55) per share-7.11VASOVaso$89.10M0.38$0.04 per share4.73$0.17 per share1.12Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHYPRHyperfine-$35.57M-$0.41N/AN/AN/A-226.88%-98.83%-67.09%8/12/2026 (Estimated)NNOXNano-X Imaging-$75.02M-$1.59N/AN/AN/A-790.87%-64.65%-57.27%7/20/2026 (Estimated)RCELAvita Medical-$48.59M-$1.57N/AN/AN/A-62.67%N/A-78.92%8/6/2026 (Estimated)VASOVaso$1.57M$0.0119.02N/AN/A1.97%6.23%2.08%N/ALatest VASO, HYPR, NNOX, and RCEL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2026Q1 2026VASOVasoN/A$999.00N/A$999.00N/A$19.36 million5/14/2026Q1 2026RCELAvita Medical-$0.35-$0.35N/A-$7.00$18.30 million$19.25 million5/12/2026Q1 2026HYPRHyperfine-$0.09-$0.09N/A-$0.09$3.54 million$3.90 million4/20/2026Q4 2025NNOXNano-X Imaging-$0.15-$0.50-$0.35-$0.50$3.99 million$3.72 million3/31/2026Q4 2025VASOVasoN/A$0.01N/A$0.01N/A$27.02 million3/18/2026Q4 2025HYPRHyperfine-$0.08-$0.06+$0.02-$0.06$5.30 million$5.29 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthHYPRHyperfineN/AN/AN/AN/AN/ANNOXNano-X ImagingN/AN/AN/AN/AN/ARCELAvita MedicalN/AN/AN/AN/AN/AVASOVasoN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHYPRHyperfine0.385.524.90NNOXNano-X ImagingN/A3.963.77RCELAvita MedicalN/A0.470.38VASOVasoN/A1.671.65Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHYPRHyperfine15.03%NNOXNano-X Imaging21.49%RCELAvita Medical27.66%VASOVasoN/AInsider OwnershipCompanyInsider OwnershipHYPRHyperfine26.33%NNOXNano-X Imaging7.74%RCELAvita Medical2.80%VASOVaso43.85%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHYPRHyperfine19099.27 million73.13 millionOptionableNNOXNano-X Imaging19069.59 million64.20 millionOptionableRCELAvita Medical13030.78 million29.92 millionOptionableVASOVaso260176.00 million98.82 millionNot OptionableVASO, HYPR, NNOX, and RCEL HeadlinesRecent News About These CompaniesVaso Corporation (OTCMKTS:VASO) Short Interest UpdateJune 13 at 1:10 AM | americanbankingnews.comVaso (OTCMKTS:VASO) Shares Pass Above Two Hundred Day Moving Average - Here's What HappenedJune 9, 2026 | americanbankingnews.comVaso Stock Gains Post Q1 Earnings, Deferred Revenue GrowsMay 21, 2026 | zacks.comVaso Corporation Announces Financial Results for First Quarter of 2026May 15, 2026 | globenewswire.comNovo Nordisk: Etavopivat is the first in a new class of drugs to meet both co-primary endpoints in the phase 3 HIBISCUS trial, substantially reducing vaso-occlusive crisis ...April 21, 2026 | manilatimes.netMCorn In A Cup (Elote En Vaso) RecipeApril 20, 2026 | yahoo.comVaso Corporation (VASO) stock price, news, quote and history - Yahoo FinanceApril 4, 2026 | sg.finance.yahoo.comVaso Stock Declines Post Q4 Earnings Despite Revenue GrowthApril 2, 2026 | zacks.comVaso Corporation Announces Financial Results for Fourth Quarter and Full Year 2025March 31, 2026 | markets.businessinsider.comVaso shareholders reelect directors and adopt triennial say-on-payDecember 19, 2025 | tipranks.comVaso Corporation Announces Fifth Extension of Sales Representation Agreement with GE HealthCareDecember 17, 2025 | globenewswire.comPositive results for Casgevy but with one patient death from myeloablative busulfan conditioning | ASH 2025December 7, 2025 | managedhealthcareexecutive.comMExa-cel shows complete success in early pediatric trials for sickle cell disease and beta-thalassemiaDecember 7, 2025 | news-medical.netNExa-cel gene therapy may off effective cure for beta-thalassemia and sickle cell disease in children younger than 12December 6, 2025 | medicalxpress.comM‘Extremely encouraging’: Exa-cel benefits kids with sickle cell disease, beta thalassemiaDecember 6, 2025 | healio.comHNanox to acquire VHC IT to accelerate AI deployment in USNovember 21, 2025 | msn.comVASO Food Bank serves veterans during time of high food insecurityNovember 21, 2025 | mvskokemedia.comMVaso Sells Subsidiary VasoHealthcare IT to Nano-XNovember 20, 2025 | tipranks.comNanox Imaging to Acquire VasoHealthcare IT for U.S. AI ExpansionNovember 20, 2025 | msn.comNanox Reaches Agreement with Vaso Corporation to Acquire VasoHealthcare IT, Accelerating U.S.November 19, 2025 | caledonianrecord.comCNew MarketBeat Followers Over TimeMedia Sentiment Over TimeVASO, HYPR, NNOX, and RCEL Company DescriptionsHyperfine NASDAQ:HYPR$1.36 -0.06 (-4.23%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$1.38 +0.02 (+1.76%) As of 06/12/2026 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.Nano-X Imaging NASDAQ:NNOX$1.76 +0.05 (+2.92%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$1.77 +0.01 (+0.51%) As of 06/12/2026 07:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode. The company's solutions include Nanox Multi Source System comprising Nanox.ARC, a medical tomographic imaging system incorporating its digital X-ray source, and Nanox. CLOUD, a platform which employs a matching engine to match medical images to radiologists that provides image repository, connectivity to diagnostic assistive AI systems, billing, and reporting. It also offers Nanox.MARKETPLACE, which connects imaging facilities with radiologists and enables radiologists to provide, as well as customers to obtain remote interpretations of imaging data; artificial intelligence (AI)-based software imaging solutions to hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers that are designed to identify or predict undiagnosed or underdiagnosed medical conditions through the mining of data included in images of existing computed tomography scans for osteoporosis and cardiovascular disease; Teleradiology Services, which provide imaging interpretation services for radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities; and multi-specialty physician groups, contracts, and radiology readings. The company is headquartered in Petach Tikva, Israel.Avita Medical NASDAQ:RCEL$3.91 -0.06 (-1.51%) Closing price 06/12/2026 04:00 PM EasternExtended Trading$3.96 +0.05 (+1.28%) As of 06/12/2026 06:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.Vaso OTCMKTS:VASO$0.19 +0.00 (+1.17%) As of 06/12/2026 03:53 PM EasternVaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas SpaceX Rings the Bell and Shatters Every Record Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story? ERock IPO: A $1.3B Power Play Solution TJX: Retail’s Apex Predator Feasts on Inflation Boeing’s Unseen Rebound: Why the Headlines Are Wrong Why Oracle's 10% Drop May Be Telling the Wrong Story Spotify's "North Star" Outlook Was Music to Investors Ears This Energy Stock Has Quietly Soared 130% in a Year Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
